Daily non-political popular news in brief.

Preoperative chemotherapy is a safe option for women with early stage operable breast cancer

Chemotherapy is frequently given to women with breast cancer after surgery to remove the main bulk of the tumor. A new Cochrane Systematic Review of existing data shows, however, that using chemotherapy to reduce the size of tumors before surgery does not compromise survival rates and enables women to retain better self-image and overall health because of the reduced impact of the surgery.

Read more »

Keywords: preoperative, chemotherapy, safe, option, women, stage, operable, breast, cancer

« Previous | Next »

Similar news on "Preoperative chemotherapy is a safe option for women with early stage operable breast cancer":

1. Chemotherapy more effective when given before breast cancer surgery
   05-10-2007 · EurekAlert!
   Giving chemotherapy to women with operable breast cancer before they have surgery -- not after -- helps physicians pin down the best treatment regimen and can reduce the extent of surgery, according to a new systematic review.
   Similar news · Read more »
   
2. Increasing radiation dose shortens treatment time for women who choose breast sparing treatment
   05-29-2007 · EurekAlert!
   Radiation therapy after lumpectomy for early-stage breast cancer can be safely delivered in higher daily doses to greatly reduce treatment time. This conclusion of a new Fox Chase Cancer Center study is good news for women who might opt to have a mastectomy instead of a lumpectomy because of the time commitment needed for the usual six-week radiation course with the breast-sparing surgical option.
   Similar news · Read more »
   
3. Herceptin does not increase heart failure in patients long-term
   06-03-2007 · EurekAlert!
   Risk of congestive heart failure in women treated with trastuzumab and combination chemotherapy for early-stage breast cancer did not increase over time according to a five-year follow-up of National Surgical Adjuvant Breast and Bowel Project trial B-31 led by the University of Pittsburgh School of Medicine. Based on the findings, the research team developed a prediction model to help oncologists assess the risk of heart failure in individual breast cancer patients prior to treatment with Herceptin and chemotherapy.
   Similar news · Read more »
   
4. Analysis confirms benefits of combining trastuzumab and chemotherapy
   07-07-2007 · EurekAlert!
   A recent meta-analysis of five major breast cancer trials has confirmed that combination treatment with the antibody trastuzumab and chemotherapy improves survival in women with operable HER-2 positive breast cancer.
   Similar news · Read more »
   
5. Herceptin plus chemotherapy significantly increases disease-free survival in breast cancer
   12-14-2006 · EurekAlert!
   Combining the molecularly targeted therapy Herceptin with chemotherapy in women with early stage breast cancer significantly improves disease-free survival for patients with a specific genetic mutation that results in very aggressive disease, a top UCLA researcher reported Thursday.
   Similar news · Read more »
   
6. Herceptin does not increase heart failure in patients long term
   06-03-2007 · EurekAlert!
   Risk of congestive heart failure in women treated with trastuzumab and combination chemotherapy for early stage breast cancer did not increase over time according to a five-year follow up of National Surgical Adjuvant Breast and Bowel Project trial B-31 led by the University of Pittsburgh School of Medicine. Based on the findings, the research team developed a prediction model to help oncologists assess the risk of heart failure in individual breast cancer patients prior to treatment with Herceptin and chemotherapy.
   Similar news · Read more »
   
7. Disparities in breast cancer treatment shown for women with disabilities
   11-06-2006 · EurekAlert!
   Among women receiving treatment for early-stage breast cancer, patients with disabilities had higher breast cancer mortality rates and were less likely than other women to receive standard treatment following breast-conserving surgery, according to a study in the November 7 issue of the Annals of Internal Medicine.
   Similar news · Read more »
   
8. Study aims to find which breast cancer patients need chemotherapy
   03-12-2007 · EurekAlert!
   Most postmenopausal women with small breast tumors don’t need chemotherapy to reduce their recurrence risk after lumpectomy.
   Similar news · Read more »
   
9. Ireland Cancer Center researcher finds standard treatment for breast cancer not followed
   12-21-2007 · EurekAlert!
   Research out of the Ireland Cancer Center of University Hospitals Case Medical Center, in collaboration with six integrated health plans that are part of the Cancer Research Network, found that the majority of older women with early stage breast cancer fail to adhere to the standard of treatment -- five years of daily oral use of the chemo-prevention drug Tamoxifen.
   Similar news · Read more »
   
10. Order of chemotherapy, radiation has no effect on breast cancer survival
    10-30-2006 · EurekAlert!
    For women who have had surgery for early breast cancer, it may not matter whether they receive follow-up chemotherapy before, after or during radiation therapy, according to a new review of studies.
    Similar news · Read more »